arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Coherus Oncology, Inc.

CHRS

$1.26 ▼ -0.19 (-12.76%) at close

15 Visible periods

28 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Weak

Neutral

auto_awesome

Analytical Summary

Coherus Oncology, Inc. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $147.6M

Dividend Yield —

Revenue Growth 59.8% ↗

Op. Margin -429.5%

ROIC -296.9% ↘

FCF / Share $-1.18 ↘

Trailing P/E 0.9x

Price / Book 2.5x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 6, 2026.

15-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$42.17M

↑ +59.8% —

Net Income Profit after all expenses

$168.02M

↑ +489.4% —

Operating Margin Operating profit as % of sales

-429.5%

↓ -443.8% 0th

FCF / Share Free cash flow per share

$-1.18

↓ -562.7% —

trending_up

Bullish Indicators

Return on Common Equity (%)Return on Common Equity (%) is in the top quartile

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↓

Returns

100

Financial Health ↓

Cash Quality

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Revenue Growth YoY (%)	59.8% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+648%)	-89.7% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1222%)	21.9% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+174%)	-35.4% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-542%)	-31.4% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-492%)	33.6% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+320%)	—	N/M	-99.2% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1340%)	532.8% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+6560%)	-3.4% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-143%)	1030.7% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+12784%)	44.9% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+461%)	—	—
EPS Growth YoY (%)	472.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	N/M	32.7% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	1.3% Caution Caution Year-over-year change in earnings per share Optimal: > 10%	N/M	43.4% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	N/M	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	489.4% Excellent ↑ Excellent Improving Year-over-year change in net income	N/M	18.5% Good ↓ Good Declining Year-over-year change in net income	-1.6% Weak Weak Year-over-year change in net income	N/M	47.2% Excellent ↑ Excellent Improving Year-over-year change in net income	N/M	12.1% Fair ↑ Fair Improving Year-over-year change in net income	-87.0% Weak ↓ Weak Declining Year-over-year change in net income	43.0% Excellent ↑ Excellent Improving Year-over-year change in net income	-156.2% Weak ↓ Weak Declining Year-over-year change in net income	-62.5% Weak Weak Year-over-year change in net income	-62.4% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	-562.7% Weak ↓ Weak Declining Year-over-year change in free cash flow	90.4% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	40.6% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-510.3% Weak Weak Year-over-year change in free cash flow	N/M	440.3% Excellent Excellent Year-over-year change in free cash flow	N/M	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	-41.5% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-56.8% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-18.5% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-16.0% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	—	573.7% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	23.3% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	—	-63.2% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	310.4% Excellent Excellent Compound annual revenue growth over 3 years	151.0% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	-38.4% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	-40.6% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	—	167.0% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	11.4% Good ↓ Good Declining Compound annual revenue growth over 5 years	73.8% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	62.8% Excellent Excellent Compound annual revenue growth over 5 years	—	-3.9% Weak Weak Compound annual revenue growth over 5 years	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Operating Margin (%) (%)	-429.5% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2963%)	—	-79.0% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-627%)	-121.7% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-911%)	-80.8% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-639%)	32.9% Excellent Excellent Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+119%)	30.3% Excellent Excellent Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+102%)	—	—	-61.0% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-507%)	—	-207.9% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1486%)	—	—	—
Effective Tax Rate (%) (%)	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.2% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	2.6% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	3.2% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—
Profit Margin (%) (%)	—	—	-92.5% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-871%)	-138.2% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1252%)	-87.9% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-833%)	27.8% Excellent Excellent Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+132%)	25.2% Excellent Excellent Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+110%)	—	—	-67.0% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-658%)	—	-280.1% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2434%)	—	—	—
FCF Margin (%) (%)	-328.4% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-77.5% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-68.1% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-115.2% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-11.9% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	30.9% Excellent Excellent Free cash flow as a percentage of revenue Optimal: > 10%	7.5% Caution Caution Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—
FCF / Net Income (x)	-0.82x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-0.72x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.74x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.83x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.13x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.11x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.30x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.76x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.86x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Return on Invested Capital (%)	-296.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	151.3% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	104.9% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	186.9% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-270.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	54.2% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	99.2% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	—	-576.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-446.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	2788.2% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-76.5% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	29.3% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—	—
Return on Capital (%) (%)	-70.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-44.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-32.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-53.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-38.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	18.6% Excellent ↑ Excellent Improving Operating profit relative to total assets Optimal: > 10%	26.4% Excellent ↑ Excellent Improving Operating profit relative to total assets Optimal: > 10%	-205.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-142.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-65.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-103.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-34.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	-75.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	275.4% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1736%)	-21.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-244%)	123.0% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+720%)	212.3% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1315%)	-293.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-2059%)	47.1% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+214%)	85.4% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+469%)	—	—	—	—	-130.4% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-970%)	55.2% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+268%)	—	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Interest Coverage (x)	-20.12x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-18.60x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-5.01x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-7.91x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-11.49x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	7.39x Good ↑ Good Improving Operating income divided by interest expense Optimal: > 5x	6.12x Good ↑ Good Improving Operating income divided by interest expense Optimal: > 5x	-21.11x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-24.30x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-14.53x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-6638.39x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-16.59x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	-6.80x Weak Weak Operating income divided by interest expense Optimal: > 5x	-25.44x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-88.88M	$-125.99M	$-102.89M	$-63.55M	$-417.19M	$-541.16M	$-177.67M	$-72.36M	$-126.91M	$-124.95M	$-158.23M	$-150.39M	$-39.55M	$-14.55M	$-7.68M

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Revenue per Share (USD)	$0.36	$0.23	$2.73	$2.72	$4.33	$6.66	$5.11	$0.00	—	—	—	$3.65	$0.57	$0.38	—
Basic EPS, GAAP (USD)	$1.43	$0.25	$-2.53	$-3.76	$-3.81	$1.85	$1.29	$-3.22	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-1.18	$-0.18	$-1.86	$-3.13	$-0.51	$2.06	$0.38	$-2.46	—	—	—	—	—	—	—
Book Value per Share (USD)	$0.50	$-1.14	$-1.72	$-1.74	$1.27	$3.87	$1.50	—	$0.53	$0.45	$-0.16	$2.01	$-20.07	—	—
Tangible Book Value per Share (USD)	$0.50	$-1.14	$-2.37	$-1.83	$1.21	$3.83	$1.44	—	$0.47	$0.37	$-0.25	$1.90	$-20.07	—	—
Basic Weighted Avg Shares (shares)	117.14M	114.55M	94.16M	77.63M	75.45M	71.41M	69.68M	65.03M	—	—	—	8.52M	4.83M	4.96M	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Working Capital (USD)	$66.32M	$58.60M	$143.86M	$242.54M	$437.00M	$621.83M	$228.04M	$51.17M	$117.08M	$105.11M	$91.37M	$127.35M	$-8.02M	—	—
Total Equity (USD)	$61.01M	$-131.99M	$-193.43M	$-137.42M	$97.73M	$280.97M	$105.21M	—	$31.82M	$20.53M	$-6.21M	$66.80M	$-97.08M	—	—

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Sales/Revenue/Turnover (USD)	$42.17M	$26.39M	$257.24M	$211.04M	$326.55M	$475.82M	$356.07M	$0.00	$1.56M	$190.11M	$30.04M	$31.11M	$2.75M	$1.90M	—
Depreciation Expense (USD)	$1.30M	$1.60M	$3.20M	$3.60M	—	—	—	—	—	—	—	—	$404.00K	$221.00K	—
Net Income, GAAP (USD)	$168.02M	$28.51M	$-237.89M	$-291.75M	$-287.10M	$132.24M	$89.83M	$-209.34M	$-238.17M	$-127.34M	$-223.26M	$-87.13M	$-53.63M	$-33.02M	—
Operating Cash Flow (USD)	$-138.51M	$-20.44M	$-174.88M	$-241.12M	$-37.43M	$154.15M	$28.36M	$-159.27M	$-200.29M	—	—	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 15 years · 54 quarters

Coherus Oncology, Inc.

Analytical Summary

15-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare CHRS with peers